$CYCU

Cycurion (CYCU) lists CFO as insider but reports no trades

Cycurion (CYCU) filed a Form 3 for CFO Ana Lucia Garcia, reporting no trades. The filing identifies her as an officer with no buy, sell, or derivative transactions. This is an initial beneficial ownership statement.

Original reporting
Published Aug 20, 2026, 8:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 10:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CYCU
Neutral
high confidence
Mentioned
$CYCU
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CYCUNeutralLow
01

Why it matters

No immediate market impact is expected, but the filing establishes a reference point for tracking the CFO's future equity activity.

02

Market read

The filing is a routine regulatory disclosure with minimal trading relevance.

03

What to watch

Potential future insider transactions or changes in compensation that are not yet reflected.

Relevance 4/10Novelty 3/10Timing: filing today

Background

Form 3 is the initial beneficial ownership filing required when an officer becomes an insider. It provides a baseline for future monitoring.

Company-level read

Ticker impact

$CYCUNeutralHigh confidence
Context

CFO Ana Lucia Garcia filed a Form 3 with no buy, sell, or derivative transactions.

Expected impact

little to no movement expected

Evidence & confidence

No transactions were reported, so investors have no new buying or selling signal.

Market effects

None; the filing is company‑specific and does not affect the broader sector.

None; the company is US‑listed with limited market footprint.

None

Counterpoint

Even without trades, the mere disclosure could be interpreted as a subtle signal of confidence or upcoming activity.

Key entities

  • Ana Lucia Garcia

    Chief Financial Officer of Cycurion, Inc.

  • Cycurion, Inc.

    Biotech firm listed under ticker CYCU.

Related articles

$CYCUHigh

Why Did CYCU Stock Jump 15% Today?

Cycurion (CYCU) shares rose 15% after announcing a $1M strategic partnership with a Fortune 500 company. The multi-year deal covers AI, security, and support. CYCU stock breached its 50-DMA for the first time since November 2025. The company expects growth and expansion opportunities.

$CYCUHigh

Cycurion shares surge 37% more after $54.6M health IT contract win

Cycurion Inc. (CYCU) shares rose 37% in premarket trading after securing a $54.6M, 10-year contract for health IT modernization, adding to a 496% gain the prior day. The deal is expected to generate over $5M in annual revenue starting November 2026. The company reported a narrowed net loss and improved gross margins in Q1 2026. Analysts maintain a Buy rating with a $7.00 price target. Cycurion also faces a Nasdaq delisting threat for failing to meet the minimum bid price requirement, with a hear

$CYCUHigh

1 as margins hit 29.1%, HHS award signed – Minichart

Cycurion (NASDAQ: CYCU) announced a 1-for-8 reverse stock split to meet NASDAQ requirements. The company reported a gross margin increase to 29.1% and a $54.6M 10-year HHS contract. It also authorized a $500K share repurchase program and aims for profitability by Q2 2027. CEO Kevin Kelly addressed market manipulation allegations.